Product details Supply Impact Dates Further Details
EDRONAX reboxetine 4mg
AUST R: 79745

Active Ingredients: reboxetine mesilate

Dosage From: Tablet, uncoated
 From: 24 Aug 2026

To: 01 Oct 2026 		Shortage Status: Anticipated

Availability: Available

Reason: Commercial Changes / Commercial viability